Swiss Re Corporate Solutions participated as a gold partner of the bi-annual Federation of European Risk Managers Association (FERMA) Forum, which took place in Monte Carlo from 15-18 October.
The FERMA Forum is one of the largest and most important European risk and insurance management events and is specifically designed by risk managers for risk managers and is an opportunity to improve their skills and knowledge, to help influence business decisions and to ensure that good risk management standards are integrated into business processes.
The conference provided an excellent platform for Swiss Re Corporate Solutions to highlight its growing primary lead capabilities, commitment to the local markets across Europe and expanding portfolio of commercial insurance offerings.
Fred Kleiterp, CEO EMEA and Loredana Mazzoleni Neglen, Head of Sales EMEA, led the delegation of 20 Corporate Solutions' client managers.
With more than 1,400 attendees across three days, the Corporate Solutions team were fully energized to maximise their presence. From hosting numerous strategic meetings with clients and brokers, to networking and engaging with prospects, to managing a busy exhibition stand. In addition, the team hosted a briefing on the topic of the latest Swiss Re sigma innovation solutions for the commercial insurance market. Senior executives also participated in workshops on topics of the shifting risk landscape and sustainability in the renewable energy sector. In total, the conference ran for 35 hours, with 100s of meetings, more than 80 speakers and moderators, with 4 high-level panel discussions and 15 workshops. The next FERMA Forum will take place in Berlin in November 2019.
Watch some video highlights of the Corporate Solutions team:
By the age of 65, it is estimated that 75% of physicians in low-risk specialties and 99% in high-risk specialties will have experienced a lawsuit. OB/GYNS are among the most likely to be sued among all physicians. Keeping pace with obstetrics patient safety science and risk mitigation strategies is challenging yet essential for promoting the best clinical outcomes.Learn more
It will insure mid-sized and large companies and government entities against large risks.Learn more
30 January 2018
29 November 2017